Jacqueline S Garcia

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 63

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia

Top Venues

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Livius Penter, Nicoletta Cieri, Katie Maurer, Marwan Kwok, Haoxiang Lyu, Wesley S Lu, Giacomo Oliveira, Satyen H Gohil, Ignaty Leshchiner, Caleb A Lareau, Leif S Ludwig, Donna S Neuberg, Haesook T Kim, Shuqiang Li, Lars Bullinger, Jerome Ritz, Gad A Getz, Jacqueline S Garcia, Robert J Soiffer, Kenneth J Livak, Catherine J Wu
Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations. Blood cancer discovery (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery (2024)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S Cutler, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Daniel J DeAngelo, Richard M Stone, Denbaa Bat-Erdene, Jeremy Adam Ryan, Manuel E Contreras, Geoffrey G Fell, Anthony Letai, Jerome Ritz, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML. Blood advances 8 (4) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology 99 (4) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S Cutler, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Daniel J DeAngelo, Richard M Stone, Denbaa Bat-Erdene, Jeremy Adam Ryan, Manuel E Contreras, Geoffrey G Fell, Anthony Letai, Jerome Ritz, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML. Blood advances 8 (4) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia 38 (9) (2024)
Pinkal M Desai, Sagar Lonial, Amanda F Cashen, Manali Kamdar, Ian W Flinn, Susan M O'Brien, Jacqueline S Garcia, Neha Korde, Javid J Moslehi, Margaret Wey, Patricia Cheung, Shringi Sharma, Damilola Olabode, Hong Chen, Firasath Ali Syed, Mary Liu, Marcio Andrade-Campos, Tapan Mahendra Kadia, James S Blachly
A PHASE 1 FIRST-IN-HUMAN STUDY OF THE MCL-1 INHIBITOR AZD5991 IN PATIENTS WITH RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Ayalew Tefferi, Giovanni Barosi, Francesco Passamonti, Juan Carlos Carlos Hernández-Boluda, Prithviraj Bose, Konstanze Döhner, Martin Ellis, Naseema Gangat, Jacqueline S Garcia, Heinz Gisslinger, Jason Gotlib, Paola Guglielmelli, Vikas K Gupta, Claire N Harrison, Elizabeth O Hexner, Gabriela S Hobbs, Jean-Jacques Kiladjian, Steffen Koschmieder, Nicolaus M Kröger, Andrew T Kuykendall, Giuseppe Gaetano Loscocco, John O Mascarenhas, Lucia Masarova, Ruben A Mesa, Barbara Mora, Olatoyosi Odenike, Stephen T Oh, Animesh D Pardanani, Anand Ashwin Patel, Naveen Pemmaraju, Alessandro Rambaldi, Raajit K Rampal, Shireen Sirhan, Natasha Szuber, Moshe Talpaz, Pankit Vachhani, Alessandro M Vannucchi, Tiziano Barbui
Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis. Blood (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology 99 (4) (2024)
Rahul S Vedula, Hannah Q Karp, Jeremy Koob, Felicia Lim, Jacqueline S Garcia, Eric S Winer, Marlise R Luskin, Gabriel Ghiaur, Annette S Kim, Lan W Beppu, Olga Sala-Torra, Jerald P Radich, Jonathan Samuel Gootenberg, Omar Abudayyeh, Feng Zhang, R Coleman Lindsley
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias. Blood (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology (2024)
Joost B Koedijk, Inge van der Werf, Livius Penter, Marijn A Vermeulen, Farnaz Barneh, Alicia Perzolli, Joyce I Meesters-Ensing, Dennis S Metselaar, Thanasis Margaritis, Marta Fiocco, Hester A de Groot-Kruseman, Rubina Moeniralam, Kristina Bang Christensen, Billie Porter, Kathleen Pfaff, Jacqueline S Garcia, Scott J Rodig, Catherine J Wu, Henrik Hasle, Stefan Nierkens, Mirjam E Belderbos, Christian Michel Zwaan, Olaf Heidenreich
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia. Leukemia (2024)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S Cutler, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Daniel J DeAngelo, Richard M Stone, Denbaa Bat-Erdene, Jeremy Adam Ryan, Manuel E Contreras, Geoffrey G Fell, Anthony Letai, Jerome Ritz, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML. Blood advances 8 (4) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia 38 (9) (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology 99 (4) (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S Cutler, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman M Shapiro, Daniel J DeAngelo, Richard M Stone, Denbaa Bat-Erdene, Jeremy Adam Ryan, Manuel E Contreras, Geoffrey G Fell, Anthony Letai, Jerome Ritz, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Prophylactic maintenance with venetoclax/azacitidine after reduced intensity conditioning allo-transplant for high risk MDS and AML. Blood advances (2024)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S Cutler, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Daniel J DeAngelo, Richard M Stone, Denbaa Bat-Erdene, Jeremy Adam Ryan, Manuel E Contreras, Geoffrey G Fell, Anthony Letai, Jerome Ritz, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML. Blood advances 8 (4) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia 38 (9) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence J Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia (2024)
Joost B Koedijk, Inge van der Werf, Livius Penter, Marijn A Vermeulen, Farnaz Barneh, Alicia Perzolli, Joyce I Meesters-Ensing, Dennis S Metselaar, Thanasis Margaritis, Marta Fiocco, Hester A de Groot-Kruseman, Rubina Moeniralam, Kristina Bang Christensen, Billie Porter, Kathleen Pfaff, Jacqueline S Garcia, Scott J Rodig, Catherine J Wu, Henrik Hasle, Stefan Nierkens, Mirjam E Belderbos, Christian Michel Zwaan, Olaf Heidenreich
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia. Leukemia (2024)
Mikkael A Sekeres, Nina Kim, Amy E DeZern, Kelly J Norsworthy, Jacqueline S Garcia, R Angelo de Claro, Marc R Theoret, Emily Y Jen, Lori A Ehrlich, Amer M Zeidan, Rami S Komrokji
Considerations for Drug Development in Myelodysplastic Syndromes. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Shai Shimony, Geoffrey G Fell, Evan C Chen, Harrison K Tsai, Martha Wadleigh, Eric S Winer, Jacqueline S Garcia, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, R Coleman Lindsley, Richard M Stone
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients age ≥60 years. Blood advances (2023)
Amer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf, Maximilian Stahl, Lionel Ades, Uma Borate, David T Bowen, Rena J Buckstein, Andrew M Brunner, Hetty E Carraway, Naval G Daver, Maria Diez Campelo, Theo M de Witte, Amy E DeZern, Fabio Efficace, Guillermo Garcia-Manero, Jacqueline S Garcia, Ulrich Germing, Aristoteles Giagounidis, Elizabeth A Griffiths, Robert P Hasserjian, Eva Hellström-Lindberg, Marcelo C Iastrebner, Rami S Komrokji, Austin G Kulasekararaj, Luca Malcovati, Yasushi Miyazaki, Olatoyosi Odenike, Valeria Santini, Guillermo F Sanz, Phillip Scheinberg, Reinhard Stauder, Arjan A Van de Loosdrecht, Andrew H Wei, Mikkael A Sekeres, Pierre Fenaux
Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes. Blood (2023)
Amer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf, Maximilian Stahl, Lionel Ades, Uma Borate, David T Bowen, Rena J Buckstein, Andrew M Brunner, Hetty E Carraway, Naval G Daver, Maria Diez Campelo, Theo M de Witte, Amy E DeZern, Fabio Efficace, Guillermo Garcia-Manero, Jacqueline S Garcia, Ulrich Germing, Aristoteles Giagounidis, Elizabeth A Griffiths, Robert P Hasserjian, Eva Hellström-Lindberg, Marcelo C Iastrebner, Rami S Komrokji, Austin G Kulasekararaj, Luca Malcovati, Yasushi Miyazaki, Olatoyosi Odenike, Valeria Santini, Guillermo F Sanz, Phillip Scheinberg, Reinhard Stauder, Arjan A Van de Loosdrecht, Andrew H Wei, Mikkael A Sekeres, Pierre Fenaux
Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes. Blood (2023)
Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R Luskin, Dzifa Yawa Duose, Rebecca S Slack Tidwell, Nicholas James Short, Gautam Borthakur, Tapan Mahendra Kadia, Lucia Masarova, George D Tippett, Prithviraj Bose, Elias J Jabbour, Farhad Ravandi, Naval G Daver, Guillermo Garcia Manero, Hagop M Kantarjian, Jacqueline S Garcia, Paresh Vyas, Koichi Takahashi, Marina Y Konopleva, Courtney D D DiNardo
A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies. Blood cancer discovery (2023)
Elyse A Olesinski, Karanpreet S Bhatia, Aarthi Nivasini Mahesh, Shazwina Rosli, Jameelah S Mohamed, Wei-Ying Jen, Nitin Jain, Jacqueline S Garcia, Gee Chuan Wong, Melissa Gaik-Ming Ooi, Anthony Letai, Marina Y Konopleva, Shruti Bhatt
BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia. Blood advances (2023)
Livius Penter, Yang Liu, Jacquelyn O Wolff, Lin Yang, Len Taing, Aashna Jhaveri, Jackson Southard, Manishkumar Patel, Nicole Cullen, Kathleen Lindahl Pfaff, Nicoletta Cieri, Giacomo Oliveira, Seunghee Kim-Schulze, Srinika Ranasinghe, Rebecca Leonard, Taylor Robertson, Elizabeth A Morgan, Helen Chen, Minkyung H Song, Magdalena Thurin, Shuqiang Li, Scott J Rodig, Carrie Cibulskis, Stacey Gabriel, Pavan Bachireddy, Jerome Ritz, Howard Streicher, Donna Neuberg, F Stephen Hodi, Sacha Gnjatic, Matthew S Davids, Kenneth J Livak, Jennifer Altreuter, Franziska Michor, Robert J Soiffer, Jacqueline S Garcia, Catherine J Wu
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease. Blood (2023)
Livius Penter, Yang Liu, Jacquelyn O Wolff, Lin Yang, Len Taing, Aashna Jhaveri, Jackson Southard, Manishkumar Patel, Nicole Cullen, Kathleen Lindahl Pfaff, Nicoletta Cieri, Giacomo Oliveira, Seunghee Kim-Schulze, Srinika Ranasinghe, Rebecca Leonard, Taylor Robertson, Elizabeth A Morgan, Helen Chen, Minkyung H Song, Magdalena Thurin, Shuqiang Li, Scott J Rodig, Carrie Cibulskis, Stacey Gabriel, Pavan Bachireddy, Jerome Ritz, Howard Streicher, Donna Neuberg, F Stephen Hodi, Sacha Gnjatic, Matthew S Davids, Kenneth J Livak, Jennifer Altreuter, Franziska Michor, Robert J Soiffer, Jacqueline S Garcia, Catherine J Wu
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease. Blood (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Livius Penter, Yang Liu, Jacquelyn O Wolff, Lin Yang, Len Taing, Aashna Jhaveri, Jackson Southard, Manishkumar Patel, Nicole Cullen, Kathleen Lindahl Pfaff, Nicoletta Cieri, Giacomo Oliveira, Seunghee Kim-Schulze, Srinika Ranasinghe, Rebecca Leonard, Taylor Robertson, Elizabeth A Morgan, Helen Chen, Minkyung H Song, Magdalena Thurin, Shuqiang Li, Scott J Rodig, Carrie Cibulskis, Stacey Gabriel, Pavan Bachireddy, Jerome Ritz, Howard Streicher, Donna Neuberg, F Stephen Hodi, Sacha Gnjatic, Matthew S Davids, Kenneth J Livak, Jennifer Altreuter, Franziska Michor, Robert J Soiffer, Jacqueline S Garcia, Catherine J Wu
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease. Blood (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Ali AlJabban, Hyun-Il Paik, Jon C Aster, Nancy Berliner, Jennifer Brouillard, Jennifer R Brown, Kathleen H Burns, Jorge J Castillo, James Card, Paola Dal Cin, Daniel J DeAngelo, David M Dorfman, Benjamin L Ebert, Jacqueline S Garcia, Caron A Jacobson, Hakim Lakhani, Jacob P Laubach, Azra H Ligon, Neal I Lindeman, R Coleman Lindsley, Scott B Lovitch, Marlise R Luskin, Elizabeth A Morgan, Andrew Nowak, Athena Petrides, Geraldine S Pinkus, Olga Pozdnyakova, David P Steensma, Richard M Stone, Olga K Weinberg, Eric S Winer, Annette S Kim
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing. JCO oncology practice (2023)
Andrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, Jada Lauren N Garzon, Ilene Galinsky, Emilie W Baxter, Rebecca Leonard, Daniel J DeAngelo, Marlise R Luskin, Christopher R Reilly, Maximilian Stahl, Richard M Stone, Rahul S Vedula, Martha Wadleigh, Eric S Winer, Tariq I Mughal, Christopher Brooks, Ira V Gupta, Kristen E Stevenson, Donna S Neuberg, Siyang Ren, Julia H Keating, Marina Y Konopleva, Anthony S Stein, Naveen Pemmaraju
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia. Blood advances (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Joan How, Jacqueline S Garcia, Ann Mullally
Biology and therapeutic targeting of molecular mechanisms in MPN. Blood (2022)
Amer M Zeidan, Uma Borate, Daniel A Pollyea, Andrew M Brunner, Fernando Roncolato, Jacqueline S Garcia, Robin Filshie, Olatoyosi Odenike, Anne Marie Watson, Ravitharan Krishnadasan, Ashish Bajel, Kiran Naqvi, Jiuhong Zha, Wei-Han Cheng, Ying Zhou, David Hoffman, Jason G Harb, Jalaja Potluri, Guillermo Garcia Manero
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes. American journal of hematology (2022)
Jacqueline S Garcia, Yael Flamand, Livius Penter, Michael Keng, Benjamin Tomlinson, Lourdes M Mendez, Paul B Koller, Nicole Cullen, Yohei Arihara, Kathleen Lindahl Pfaff, Jacquelyn O Wolff, Andrew M Brunner, Ilene Galinsky, Asad Bashey, Joseph H Antin, Corey S Cutler, Vincent T Ho, Brian A Jonas, Marlise R Luskin, Martha Wadleigh, Eric S Winer, Alexandra Savell, Rebecca Leonard, Taylor Robertson, Matthew S Davids, Howard Streicher, Scott J Rodig, Jerome Ritz, Catherine J Wu, Daniel J DeAngelo, Donna Neuberg, Richard M Stone, Robert J Soiffer
Ipilimumab plus decitabine for patients with MDS or AML in post-transplant or transplant naïve settings. Blood (2022)
Claire N Harrison, Jacqueline S Garcia, Tim C P Somervaille, James M Foran, Srdan Verstovsek, Catriona Jamieson, Ruben A Mesa, Ellen K Ritchie, Srinivas K Tantravahi, Pankit Vachhani, Casey L O'Connell, Rami S Komrokji, Jason Harb, Jessica E Hutti, Leanne Holes, Abdullah A Masud, Silpa Nuthalapati, Jalaja Potluri, Naveen Pemmaraju
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (15) (2022)
Marina Konopleva, Michael J Thirman, Keith W Pratz, Jacqueline S Garcia, Christian Recher, Vinod Pullarkat, Hagop M Kantarjian, Courtney D D DiNardo, Monique Dail, Yinghui Duan, Brenda J Chyla, Jalaja Potluri, Catherine L Miller, Andrew H Wei
Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Naval G Daver, Monique Dail, Jacqueline S Garcia, Brian A Jonas, Karen W L Yee, Kevin R Kelly, Norbert Vey, Sarit Assouline, Gail J Roboz, Stefania Paolini, Daniel A Pollyea, Agostino Tafuri, Joseph M Brandwein, Arnaud Pigneux, Bayard L Powell, Pierre Fenaux, Rebecca L Olin, Giuseppe Visani, Giovanni Martinelli, Maika Onishi, Jue Wang, Weize Huang, Cherie Green, Marion G Ott, Wan-Jen Hong, Marina Y Konopleva, Michael Andreeff
Venetoclax and idasanutlin in relapsed/refractory AML: a non-randomized, open-label phase 1b trial. Blood (2022)
Joan How, Jacqueline S Garcia, Ann Mullally
Biology and therapeutic targeting of molecular mechanisms in MPN. Blood (2022)
Eva J Schaefer, Helen C Wang, Hannah Q Karp, Clifford A Meyer, Paloma Cejas, Micah D Gearhart, Emmalee R Adelman, Iman Fares, Annie Apffel, Klothilda Lim, Yingtian Xie, Christopher J Gibson, Monica Schenone, H Moses Murdock, Eunice S Wang, Lukasz P Gondek, Martin P Carroll, Rahul S Vedula, Eric S Winer, Jacqueline S Garcia, Richard M Stone, Marlise R Luskin, Steven A Carr, Henry W Long, Vivian J Bardwell, Maria E Figueroa, R Coleman Lindsley
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes. Blood cancer discovery 3 (2) (2022)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Corey S Cutler, Jennifer Brock, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman M Shapiro, Fiona Loschi, Jeremy Adam Ryan, Geoffrey Fell, Hannah Q Karp, Jennifer A Woyach, Annette S Kim, Danielle Sinead Potter, Thelma Mashaka, Richard M Stone, Daniel J DeAngelo, Anthony Letai, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Adding venetoclax to fludarabine/busulfan RIC transplant for high risk MDS and AML is feasible, safe, and active. Blood advances (2021)
Keith W Pratz, Brian A Jonas, Vinod Pullarkat, Christian Recher, Andre C Schuh, Michael J Thirman, Jacqueline S Garcia, Courtney D D DiNardo, Vladimir Vorobyev, Nicola Stefano Fracchiolla, Su-Peng Yeh, Jun Ho Jang, Muhit Özcan, Kazuhito Yamamoto, Arpad Illes, Ying Zhou, Monique Dail, Brenda Chyla, Jalaja Potluri, Hartmut Döhner
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (8) (2021)
Andrew Hantel, Marlise R Luskin, Jacqueline S Garcia, Wendy Stock, Daniel J DeAngelo, Gregory A Abel
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials. Blood advances 5 (21) (2021)
Jacqueline S Garcia, Shruti Bhatt, Geoffrey Fell, Adam S Sperling, Michael Burgess, Hasmik Keshishian, Binyam Yilma, Andrew Brunner, Donna Neuberg, Steven A Carr, Benjamin L Ebert, Karen Ballen, Richard M Stone, Daniel J DeAngelo, Bruno C Medeiros, Anthony Letai
Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re-induction chemotherapy. American journal of hematology 95 (3) (2019)